ADVERTISEMENT

BCMA in MM

Kevin Boyd, PhD, on the Safety, Efficacy of Belantamab Mafodotin With B-Vd for R/R MM

Videos

Kevin Boyd, PhD, on the Safety, Efficacy of Belantamab Mafodotin With B-Vd for R/R MM

12/29/2020

Dr Boyd highlights details of the phase 3 DREAMM-7 trial, examining the efficacy and safety of belantamab mafodotin with bortezomib and dexamethasone for relapsed/refractory MM.

Dr Boyd highlights details of the phase 3 DREAMM-7 trial, examining the efficacy and safety of belantamab mafodotin with bortezomib and dexamethasone for relapsed/refractory MM.

Dr Boyd highlights details of...

12/29/2020

Oncology

$Paul Richardson, MD, Discusses Belantamab Mafodotin for Relapsed/Refractory MM$

Conference Insider

Paul Richardson, MD, Discusses Belantamab Mafodotin for Relapsed/Refractory MM

12/10/2020

Dr Richardson discusses belantamab mafodotin for targeting BCMA pathways in relapsed/refractory MM, and the DREAMM-5 trial of 4 novel combo therapies for this disease.

Dr Richardson discusses belantamab mafodotin for targeting BCMA pathways in relapsed/refractory MM, and the DREAMM-5 trial of 4 novel combo therapies for this disease.

Dr Richardson discusses...

12/10/2020

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 8 ⁠–⁠ November 10

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Advertisement

Advertisement